D.E. Shaw & Co’s AEON Biopharma Inc AEON.WS Stock Holding History

D.E. Shaw & Co’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-154,432	Closed	-$224K	–	4959
2024 Q1	$224K	Hold	154,432	–	–	﹤0.01%	3880
2023 Q4	$15.4K	Hold	154,432	–	–	﹤0.01%	4082
2023 Q3	$23.2K	Buy	154,432 +121,099	+363%	+$17.2K	﹤0.01%	3976
2023 Q2	$3K	Hold	33,333	–	–	﹤0.01%	4145
2023 Q1	$2K	Hold	33,333	–	–	﹤0.01%	4360
2022 Q4	$1.52K	Hold	33,333	–	–	﹤0.01%	4779
2022 Q3	$2K	Hold	33,333	–	–	﹤0.01%	5095
2022 Q2	$5K	Hold	33,333	–	–	﹤0.01%	5234
2022 Q1	$10K	Hold	33,333	–	–	﹤0.01%	5413
2021 Q4	$17K	Hold	33,333	–	–	﹤0.01%	5303
2021 Q3	$18K	Hold	33,333	–	–	﹤0.01%	4900
2021 Q2	$34K	Buy	+33,333	New	+$25.3K	﹤0.01%	4656

D.E. Shaw & Co's AEON.WS Position: Q2 2024 in Review

D.E. Shaw & Co sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 154,432 shares — an estimated $224K sold.

D.E. Shaw & Co first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $224K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

D.E. Shaw & Co reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
D.E. Shaw & Co sold 154,432 AEON Biopharma Inc shares in Q2 2024, an estimated $224K.
D.E. Shaw & Co first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
D.E. Shaw & Co's AEON Biopharma Inc position peaked at $224K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.